Insights

Regulatory News

By Vigilare Biopharma September 22, 2023

Pharma and Regulatory News Sep 22

By Vigilare Biopharma August 28, 2023

Outsourcing Pharmacovigilance to CROs: Benefits, Challenges and Best Practices

By Vigilare Biopharma August 16, 2023

How decentralized clinical trials-DCTs are transforming clinical research and patient

FDA Approves First Oral Treatment for Postpartum Depression

By Vigilare Biopharma August 8, 2023

FDA Approves Zurzuvae: First Oral Medication for Postpartum Depression (PPD)

By Vigilare Biopharma August 1, 2023

Patient Engagement in Pharmacovigilance: Empowering Patients for Safer Healthcare

By Vigilare Biopharma July 27, 2023

Pharmacovigilance in Medical Trends: Enhancing Drug Safety in the Evolving

Regulatory News

By Vigilare Biopharma July 21, 2023

Regulatory and Pharma News July 21

By Vigilare Biopharma July 19, 2023

Pharmacovigilance Guidelines: Ensuring Global Drug Safety

An In-Depth Exploration of Pharmacovigilance: Ensuring Drug Safety through Comprehensive Safety Reports

By Vigilare Biopharma July 13, 2023

An In-Depth Exploration of Pharmacovigilance: Ensuring Drug Safety through Comprehensive

…